13 April 2020 | Features | By Ankit Kankar |Special COVID-19 Reporting
Dr. Priti V. Warke, M.B.B.S., M.S Director- Cell Culture, Head- Regulatory Affairs Hi Media Laboratories Private Limited in an Interaction with BioSpectrum India Exclusive COVID 19 reports.
As the number of COVID-19 cases continue to rise all across the globe, BioSpectrum brings together a panel of healthcare industry experts to identify gaps and work together towards making India COVID-19 free.
Watch Dr. Priti V. Warke, Sharing her Views on " How to make India COVID-19 Free "
Dr. Priti V. Warke, M.B.B.S., M.S
Director- Cell Culture, Head- Regulatory Affairs
HiMedia Laboratories Private Limited
Dr. Priti V. Warke is the director of Cell Culture division of HiMedia Laboratories. She also heads the Regulatory Affairs of the company. She completed her M.B.B.S. from B.J.Medical College, Pune and M.S. from the Catholic University of America, Washington DC. She has been involved in Research & Development, operational and administrative activities of Cell Culture wing of HiMedia.
She has been instrumental in starting the stem cell and regenerative medicine division in HiMedia. Presently she is actively involved in developing serum free media, Assay kits, cells required for manufacturing of monoclonal antibodies for cancer.
She also developed the Viral transport Medium (VTM) for H1N1 during the 2009 epidemic in a short span of 2 months. This media was later used during the pandemic all over India for transporting patient samples. The VTM kit is currently being used for collecting samples to test for coronavirus infections. HiMedia is India’s largest validated and certified manufacturer of the VTM kits. Apart from handling the business humdrums, Dr. Priti is an avid yoga practitioner and believes in meditation.